Please ensure Javascript is enabled for purposes of website accessibility
Home > Support > Customer Publications

Botulinum toxin type A attenuates trigeminal neuralgia-like pain by suppressing CGRP release and modulating NaV1.7-associated signaling

Release date: 2026-08-10  View count: 0
Recommendation

Get a free quote